Evidence map›Paper›PMID 22910029›Full record

ArticleEndocrinology2012

A potential role of progestin-induced laminin-5/α6-integrin signaling in the formation of side branches in the mammary gland.

Gabriele Meyer, Jeffrey Leipprandt, Jianwei Xie, Mark D Aupperlee, Sandra Z Haslam

Open access · bronzeAbstract read
In one paragraph

Article in Endocrinology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Gabriele MeyerDepartment of Physiology and Breast Cancer and the Environment Research Center, Michigan State University, East Lansing, Michigan 48824, USA.
Jeffrey Leipprandt
Jianwei Xie
Mark D Aupperlee
Sandra Z Haslam
Michigan State University · US

Funding

Breast Cancer and the Environment Research CenterU01ES012800 · NIEHS · MICHIGAN STATE UNIVERSITY · PI HASLAM, SANDRA Z · 2003 to 2009
$5.6M
STROMA AND MAMMARY GLAND CELL PROLIFERATIONR01CA040104 · NCI · MICHIGAN STATE UNIVERSITY · PI HASLAM, SANDRA Z · 1985 to 2007
$1.6M
NCI NIH HHS R01 CA040104NCI NIH HHS R01CA-40104NCI NIH HHS U01 ES/CA 012800NIEHS NIH HHS U01 ES012800
6 · The paper itself

Abstract

Mammary organoids from adult mice produce tubules, analogous to mammary ducts in vivo, in response to hepatocyte growth factor (HGF) when cultured in collagen gels. The combination of HGF plus progestin (R5020) causes reduced tubule number and length. We hypothesized that the inhibitory effect on tubulogenesis was due to progestin-mediated alteration of HGF/c-Met signaling. Using molecular inhibitors and short hairpin RNA, it was determined that HGF activation of Ras-related C3 botulinum toxin substrate (Rac1) was required for the formation of cytoplasmic extensions, the first step of tubulogenesis, and that Rac1 activity was Src kinase (Src) and focal adhesion kinase (FAK) dependent. The highly novel finding was that R5020 reduced tubulogenesis by up-regulating and increasing extracellular laminin and α6-integrin ligation to reduce activation of the Src, focal adhesion kinase, and Rac1 pathway. Receptor activator of nuclear factor-κB ligand, another progesterone-induced paracrine factor, did not replicate this effect of R5020. The inhibitory effect of R5020 on tubulogenesis was likely mediated through progesterone receptor (PR) isoform A (PRA), because PRA is the predominant PR isoform expressed in the organoids, and the progestin-induced effect was prevented by the PR antagonist RU486. These results provide a plausible mechanism that explains progestin/PRA-mediated blunting of HGF-induced tubulogenesis in vitro and is proposed to be relevant to progesterone/PRA-induced side-branching in vivo during pregnancy.

Indexed as

AnimalsCell AdhesionCell Adhesion MoleculesCell MovementEpithelial CellsFemaleFocal Adhesion Protein-Tyrosine KinasesHepatocyte Growth FactorHormone AntagonistsIntegrin alpha6KalininMammary Glands, AnimalMiceMifepristoneProto-Oncogene Proteins pp60(c-src)rac1 GTP-Binding ProteinCell Adhesion MoleculesFocal Adhesion Protein-Tyrosine KinasesHepatocyte Growth FactorHormone AntagonistsIntegrin alpha6KalininMifepristoneprogesterone receptor AProto-Oncogene Proteins pp60(c-src)rac1 GTP-Binding ProteinReceptors, Progesterone

Identifiers

PMID22910029
PMCPMC3512027
OpenAlexW2030549409

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.